4/2/21 20:42 | 4/1/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 1,214 | 12.51 | 0 | 97 | 30 | 425 | D | | | | | | | | | | | | | | |
4/2/21 20:42 | 4/1/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -4,161 | 82.46 | 0 | -50 | -11 | 425 | D | | | | | | | | | | | | | | |
2/9/21 20:38 | 2/9/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 384 | 18.30 | 0 | 21 | 6 | 380 | D | | | | | | | | | | | | | | |
2/9/21 20:38 | 2/9/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -862 | 75.00 | 0 | -11 | -3 | 380 | D | | | | | | | | | | | | | | |
2/3/21 21:38 | 2/1/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 1,055 | 9.68 | 0 | 109 | 42 | 371 | D | | | | | | | | | | | | | | |
2/3/21 21:38 | 2/1/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -3,498 | 64.00 | 0 | -55 | -13 | 371 | D | | | | | | | | | | | | | | |
1/5/21 20:55 | 12/31/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 0 | 0.00 | 0 | 5 | 2 | 314 | D | | | | | | | | | | | | | | |
1/5/21 20:55 | 1/5/21 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -116 | 55.86 | 0 | -2 | -1 | 314 | D | | | | | | | | | | | | | | |
12/3/20 18:42 | 12/1/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 69 | 13.88 | 0 | 5 | 2 | 311 | D | | | | | | | | | | | | | | |
12/3/20 18:42 | 12/1/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -129 | 38.21 | 0 | -3 | -1 | 311 | D | | | | | | | | | | | | | | |
11/18/20 19:55 | 11/16/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.dm | 94 | 8.25 | 0 | 11 | 4 | 309 | D | | | | | | | | | | | | | | |
11/18/20 19:55 | 11/16/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.dm | -229 | 34.36 | 0 | -7 | -2 | 309 | D | | | | | | | | | | | | | | |
11/6/20 16:41 | 11/4/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 69 | 13.88 | 0 | 5 | 2 | 305 | D | | | | | | | | | | | | | | |
11/6/20 16:41 | 11/4/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -94 | 28.00 | 0 | -3 | -1 | 305 | D | | | | | | | | | | | | | | |
10/16/20 20:58 | 10/15/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 3 | 303 | D | | | | | | | | | | | | | | |
10/16/20 20:58 | 10/15/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -136 | 24.20 | 0 | -6 | -2 | 303 | D | | | | | | | | | | | | | | |
9/17/20 16:55 | 9/15/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 3 | 299 | D | | | | | | | | | | | | | | |
9/17/20 16:55 | 9/15/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -118 | 21.04 | 0 | -6 | -2 | 299 | D | | | | | | | | | | | | | | |
8/20/20 16:13 | 8/18/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 294 | D | | | | | | | | | | | | | | |
8/20/20 16:13 | 8/18/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -118 | 21.00 | 0 | -6 | -2 | 294 | D | | | | | | | | | | | | | | |
7/17/20 16:18 | 7/15/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 290 | D | | | | | | | | | | | | | | |
7/17/20 16:18 | 7/15/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -127 | 22.70 | 0 | -6 | -2 | 290 | D | | | | | | | | | | | | | | |
6/18/20 17:00 | 6/16/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 284 | D | | | | | | | | | | | | | | |
6/18/20 17:00 | 6/16/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -118 | 21.00 | 0 | -6 | -2 | 284 | D | | | | | | | | | | | | | | |
5/28/20 17:23 | 5/26/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | M.d | 68 | 6.83 | 0 | 10 | 4 | 280 | D | | | | | | | | | | | | | | |
5/28/20 17:23 | 5/26/20 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivera Jose E | MA | O | EVP,GC | S.d | -119 | 21.21 | 0 | -6 | -2 | 280 | D | | | | | | | | | | | | | | |